Skip to main content
Explore URMC
URMC / Medicine / Allergy, Immunology, and Rheumatology / Patient Care / Lupus Clinic and Program

Lupus Clinic and Program

The Lupus Clinic and Program at the University of Rochester Medical Center is composed of a multi-disciplinary group of health care professionals who share a common vision: to find safer, more effective therapies for lupus and to improve the quality of life of patients living with lupus.

Our Services

  • lupus clinicEvaluation of new patients with a possible diagnosis of lupus or a related disease
  • Ongoing management of patients with lupus
  • Focus on patient education and preventive care
  • Provision of state-of-the-art therapies for the management of lupus

Our Goals

  • Dr Anolik at Lupus Education dayTo provide pediatric and adult patients with the highest quality of clinical care
  • To give pediatric and adult patients access to promising new therapies through clinical trials
  • To understand the basic immunologic processes underlying lupus
  • To study the factors leading to the development of lupus and develop better diagnostic tools
  • To develop a registry of lupus patients

Quick Facts About Lupus

  • Systemic Lupus Erythematosus (SLE) can vary from a mild condition to a life-threatening illness. It causes disease by attacking a person's immune system. It can inflame joints making them swell and attack the kidneys, heart, lungs and liver, leading to pain, dysfunction, and sometimes permanent damage to healthy tissues.
  • Approximately one and a half to two million Americans suffer from this potentially fatal autoimmune disease, and 90% of those are women.
  • Most women are stricken during their childbearing years.
  • Most people develop their lupus between the ages of 15 and 45.
  • Asians, African-Americans and Latina women are 2-4 times more likely to have lupus.

lupus education day seminar

Our Providers


Support for the URMC Lupus Program endeavors comes from the National Institute of Allergy and Infectious Diseases, the National Institute of Arthritis and Musculoskeletal Diseases, the Lupus Foundation of America, the Alliance for Lupus Research, and the Lupus Clinical Trials Consortium.